MM
Mitchell Mathis
Psychiatry & Neurology / Geriatric Psychiatry
Credentials: ·
Research
Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia
New England Journal of Medicine · 2017 · Last of 5 authors · 22 citations
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin
Review · The Journal of Clinical Psychiatry · 2017 · First of 7 authors
Psychiatric Research and Clinical Practice · 2021
- TF
8 papers
- EU
4 papers
- RT
4 papers
- TL
4 papers
- BM
1 paper · 1 as a resident
1 paper
- MD
1 paper
- PA
1 paper